| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,239 |
4,649 |
$247K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,342 |
2,896 |
$119K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,881 |
1,649 |
$10K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,338 |
1,226 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
286 |
262 |
$5K |
| 99490 |
Ccm add 20min |
1,293 |
1,246 |
$2K |
| 81002 |
|
1,413 |
1,294 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
110 |
54 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
291 |
272 |
$793.74 |
| 80305 |
|
155 |
143 |
$785.25 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
148 |
141 |
$528.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
371 |
344 |
$339.41 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
104 |
99 |
$302.34 |
| 0031A |
|
15 |
14 |
$240.00 |
| 87400 |
|
64 |
29 |
$210.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
872 |
801 |
$202.86 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
78 |
68 |
$103.24 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$77.84 |
| 99457 |
|
321 |
306 |
$68.40 |
| 99000 |
|
14 |
14 |
$49.00 |
| 99454 |
|
250 |
237 |
$45.16 |
| 36415 |
Collection of venous blood by venipuncture |
31 |
25 |
$28.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
17 |
15 |
$25.98 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
823 |
707 |
$0.00 |
| 1100F |
|
32 |
29 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
713 |
634 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,109 |
952 |
$0.00 |
| 0518F |
|
192 |
175 |
$0.00 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
29 |
28 |
$0.00 |
| 99307 |
|
22 |
19 |
$0.00 |
| 99080 |
|
38 |
33 |
$0.00 |
| 3078F |
|
15 |
14 |
$0.00 |
| 4004F |
|
13 |
12 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
14 |
14 |
$0.00 |
| 3077F |
|
22 |
21 |
$0.00 |
| 1101F |
|
584 |
513 |
$0.00 |
| G8866 |
Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal) |
215 |
188 |
$0.00 |
| 3074F |
|
17 |
16 |
$0.00 |
| 3080F |
|
15 |
15 |
$0.00 |
| 3079F |
|
19 |
18 |
$0.00 |
| 96127 |
|
12 |
12 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
16 |
13 |
$0.00 |